US pharma major Eli Lilly (NYSE: LLY) has lowered the price of Zepbound (tirzepatide) single-dose vials on its Lilly Direct ...

Privately-held German biotech Tacalyx has appointed Jean Engela as chief executive (CEO).

A regenerative medicine company developing stem cell-derived engineered tissues intended to restore organ function, with an ...

The Association for Accessible Medicines (AAM) has welcomed House passage of Q1/Q2 legislation embedded in the Give Kids a ...

US biotech Citius Oncology (Nasdaq: CTOR) has launched Lymphir (denileukin diftitox-cxdl), its first commercial product, ...

Regulators have squeezed a lot into the late-November cycle. In Europe, the European Medicines Agency's (EMA) Committee for ...

San Diego-based Protego Biopharma, a biotech developing small molecule therapeutics that reprogram protein folding to address ...

The UK government has sealed a deal to give the USA zero tariffs on pharmaceutical products imported into the country, in return for the National Health Service (NHS) spending more on medicines.

A pair of biosimilar companies have launched their copies of a big-selling monoclonal antibody used to treat various bone ...

Shares of US clinical-stage biotech Q32 Bio were up a massive 150% at $5.48 by mid-morning after it revealed that it has sold ...

The autism spectrum disorder (ASD) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain and Japan) is projected to grow at a compound annual growth rate (CAGR) of 18.7%, from ...

Shares of San Diego, USA-based Belite Bio shot up 16.4% to $160.00 in pre-market activity today, after it announced top-line ...